Debt-to-equity in % of AGILE THERAPEUTICS INC from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
AGILE THERAPEUTICS INC quarterly Debt-to-equity history and change rate from Q3 2020 to Q2 2024.
  • AGILE THERAPEUTICS INC Debt-to-equity for the quarter ending 30 Jun 2024 was -180 %, a 39.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 -180 +116 +39.2% 30 Jun 2024
Q1 2024 -191 +416 +68.6% 31 Mar 2024
Q4 2023 -194 +726 +78.9% 31 Dec 2023
Q3 2023 -230 +5.58K +96% 30 Sep 2023
Q2 2023 -296 -1.39K -127% 30 Jun 2023
Q1 2023 -607 -972 -266% 31 Mar 2023
Q4 2022 -920 -1.07K -702% 31 Dec 2022
Q3 2022 -5.81K -5.9K -6932% 30 Sep 2022
Q2 2022 1.09K +1.03K +1826% 30 Jun 2022
Q1 2022 366 +325 +803% 31 Mar 2022
Q4 2021 153 +122 +401% 31 Dec 2021
Q3 2021 85.1 +61.2 +256% 30 Sep 2021
Q2 2021 56.6 30 Jun 2021
Q1 2021 40.5 31 Mar 2021
Q4 2020 30.5 31 Dec 2020
Q3 2020 23.9 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.